Literature DB >> 35294634

Advantages of a robotic approach compared with laparoscopy gastrectomy for patients with high visceral fat area.

Makoto Hikage1, Keiichi Fujiya1, Yuhei Waki1, Satoshi Kamiya1, Yutaka Tanizawa1, Etsuro Bando1, Akifumi Notsu2, Masanori Terashima3.   

Abstract

BACKGROUND: Gastric cancer surgery for obese patients is regarded as a technically challenging procedure. The morbidity after gastrectomy has been reported to be significantly higher in patients with high visceral fat area (VFA). Robotic gastrectomy (RG) is expected to be advantageous for complicated operations. However, whether RG is superior to conventional laparoscopic gastrectomy (LG) for patients with visceral fat obesity remains unclear. The present study aimed to clarify the impact of RG on the short- and long-term outcomes of patients with high VFAs.
METHODS: This study included 1306 patients with clinical stage I/II gastric cancer who underwent minimally invasive gastrectomy between January 2012 and December 2020. The patients were subclassified according to VFA. The short- and long-term outcomes of RG were compared with those of LG in two VFA categories.
RESULTS: This study included 394 (high-VFA, 151; low-VFA, 243) and 882 patients (high-VFA, 366; low-VFA, 516) in the RG and LG groups, respectively. RG was associated with a significantly longer operative time than LG (high-VFA, P < 0.001; low-VFA, P < 0.001). The incidence rates of overall and intra-abdominal infectious complications in the high-VFA patients were lower in the RG group than in the LG group (P = 0.019 and P = 0.048, respectively) but not significantly different from those in the low-VFA patients. In the multivariate analysis, LG was identified as the only independent risk factor of overall (odds ratio [OR] 3.281; P = 0.012) and intra-abdominal infectious complications (OR 3.462; P = 0.021) in the high-VFA patients. The overall survival of high-VFA patients was significantly better in the RG group than in the LG group (P = 0.045).
CONCLUSIONS: For patients with visceral fat obesity, RG appears to be advantageous to LG in terms of reducing the risk of complications and better long-term survival.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Complication; Gastric cancer; Laparoscopic gastrectomy; Robotic gastrectomy; Survival; Visceral fat area

Mesh:

Year:  2022        PMID: 35294634     DOI: 10.1007/s00464-022-09178-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  45 in total

1.  Late phase II study of robot-assisted gastrectomy with nodal dissection for clinical stage I gastric cancer.

Authors:  Masanori Tokunaga; Rie Makuuchi; Yuiciro Miki; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  Surg Endosc       Date:  2015-10-28       Impact factor: 4.584

2.  Clinical advantages of robotic gastrectomy for clinical stage I/II gastric cancer: a multi-institutional prospective single-arm study.

Authors:  Ichiro Uyama; Koichi Suda; Masaya Nakauchi; Takahiro Kinoshita; Hirokazu Noshiro; Shuji Takiguchi; Kazuhisa Ehara; Kazutaka Obama; Shiro Kuwabara; Hiroshi Okabe; Masanori Terashima
Journal:  Gastric Cancer       Date:  2018-12-03       Impact factor: 7.370

Review 3.  Robotic surgery for gastric cancer.

Authors:  Masanori Terashima; Masanori Tokunaga; Yutaka Tanizawa; Etsuro Bando; Taaichi Kawamura; Yuichiro Miki; Rie Makuuchi; Shinsaku Honda; Taichi Tatsubayashi; Wataru Takagi; Hayato Omori; Fumiko Hirata
Journal:  Gastric Cancer       Date:  2015-04-22       Impact factor: 7.370

4.  Assessing the safety and efficacy of full robotic gastrectomy with intracorporeal robot-sewn anastomosis for gastric cancer: A randomized clinical trial.

Authors:  Gang Wang; Zhiwei Jiang; Jian Zhao; Jiang Liu; Shu Zhang; Kun Zhao; Xiaobo Feng; Jieshou Li
Journal:  J Surg Oncol       Date:  2016-01-12       Impact factor: 3.454

5.  Early phase II study of robot-assisted distal gastrectomy with nodal dissection for clinical stage IA gastric cancer.

Authors:  Masanori Tokunaga; Norihiko Sugisawa; Junya Kondo; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  Gastric Cancer       Date:  2013-09-05       Impact factor: 7.370

6.  Multicenter Prospective Comparative Study of Robotic Versus Laparoscopic Gastrectomy for Gastric Adenocarcinoma.

Authors:  Hyoung-Il Kim; Sang-Uk Han; Han-Kwang Yang; Young-Woo Kim; Hyuk-Joon Lee; Keun Won Ryu; Joong-Min Park; Ji Yeong An; Min-Chan Kim; Sungsoo Park; Kyo Young Song; Sung Jin Oh; Seong-Ho Kong; Byoung Jo Suh; Dae Hyun Yang; Tae Kyung Ha; Youn Nam Kim; Woo Jin Hyung
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

7.  Robotic Gastrectomy Compared with Laparoscopic Gastrectomy for Clinical Stage I/II Gastric Cancer Patients: A Propensity Score-Matched Analysis.

Authors:  Makoto Hikage; Keiichi Fujiya; Satoshi Kamiya; Yutaka Tanizawa; Etsuro Bando; Akifumi Notsu; Keita Mori; Masanori Terashima
Journal:  World J Surg       Date:  2021-01-18       Impact factor: 3.352

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Long-term outcomes of robotic gastrectomy for clinical stage I gastric cancer: a single-center prospective phase II study.

Authors:  Makoto Hikage; Masanori Tokunaga; Kenichiro Furukawa; Keiichi Fujiya; Satoshi Kamiya; Yutaka Tanizawa; Etsuro Bando; Masanori Terashima
Journal:  Surg Endosc       Date:  2020-08-11       Impact factor: 4.584

10.  Non-robotic minimally invasive gastrectomy as an independent risk factor for postoperative intra-abdominal infectious complications: A single-center, retrospective and propensity score-matched analysis.

Authors:  Susumu Shibasaki; Koichi Suda; Masaya Nakauchi; Kenichi Nakamura; Kenji Kikuchi; Kazuki Inaba; Ichiro Uyama
Journal:  World J Gastroenterol       Date:  2020-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.